7000 Cardinal Place
437 articles with Cardinal Health
Company Expects to Meet at Least the Midpoint of its Previously Announced Non-GAAP EPS Guidance for Fiscal Year '19
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2019 on August 8
Cardinal Health plans to release fourth-quarter and year-end financial results for its fiscal year 2019 on August 8 prior to the opening of trading on the New York Stock Exchange.
Cordis, a Cardinal Health company, recently announced the full U.S. launch of its RADIAL 360 portfolio, offering a complete range of products to facilitate the transradial approach for interventional cardiology procedures.
Cardinal Health reported third quarter fiscal year 2019 revenues of $35.2 billion, an increase of 5 percent.
Cardinal Health Fourth Annual Survey Finds Supply Chain Tasks Causing Stress for Clinicians and Impacting Patient Care
Clinicians report spending more than twice the amount of time they would like to on supply chain-related tasks, and as a result have less time with patients and increased stress levels, according to the fourth annual Cardinal Health Hospital Supply Chain Survey.
Philips Healthcare is the Quarter 2 Featured Supplier
The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
CoolSource™ Cooling System lowers heat induced stress for surgical staff
A New Survey from Cardinal Health Reveals Demands on Hospital Leaders' Time Take a Toll on Ability to Drive Innovation
Three ways the hospital pharmacy can improve hospital profitability and patient outcomes
GAAP(1) operating earnings increased 26 percent to $504 million, and non-GAAP operating earnings decreased 13 percent to $637 million
Cardinal Health Announces Brian Rice as EVP, Chief Information Officer and Customer Support Services
Cardinal Health (NYSE: CAH) today announced that Brian Rice will join the company as executive vice president, chief information officer and customer support services. Rice's most recent role was senior vice president, chief information officer and global business services for Kellogg Company.
Cardinal Health Foundation Supports New Initiatives at the Ohio Hospital Association to Spread Best Practices in Opioid Prescribing
Partnership builds on Cardinal Health's Opioid Action Program and Generation Rx
Cardinal Health today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee.
Assessments by AmerisourceBergen, Cardinal Health, and McKesson Pharmaceutical Shows Nearly 80 Percent of Suppliers' Packages Do Not Meet Requirements
Cardinal Health (NYSE: CAH) today announced that Victor Crawford will be joining the company as its next CEO of the Pharmaceutical Segment.
Cardinal Health plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange.
Telix Pharmaceuticals and Cardinal Health Enter into Distribution Agreement for Prostate Cancer Imaging
Telix Pharmaceuticals (US) Inc. today announced that it has entered into a distribution agreement with Cardinal Health (NYSE:CAH).
Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari™ (L-glutamine oral powder)
Company Signs Fourth Major Distribution Agreement this Year
Purdue Pharma, best known for being the manufacturer of opioid drug OxyContin, is offering free doses of a treatment for opioid abuse as part of negotiations in more than 1,000 lawsuits.
The Cardinal Health (NYSE: CAH) board of directors approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to shareholders of record at the close of business on October 1, 2018.